Stockreport

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF the use of tegoprubart to prevent islet cell transplant rejection in patients with type 1 diabetes Reported updated data from ongoing Phase 1b trial evaluating tegopru [Read more]